Full Course Description


Cardiac Medication Essentials: 2016 Critical Care Nursing Conference

Watch Dr. Paul Langlois, APN, PHD, CCRN, CCNS, CNRN, for an insightful and practical day focused on the common types of cardiac disorders that professionals like you see in your practice, and the medications currently used to treat them. Paul will provide you with cutting-edge information regarding the selection of particular cardiac medications, the desired outcomes, potential side effects and drug interactions. Don’t miss this opportunity to keep pace with the ever-changing field of cardiac care and, through the information gained in this seminar, reduce the risk of potential adverse consequences for your patients!

  • Antiarrhythmic Agents
  • Anticoagulants
  • Metabolic Syndrome
  • Dyslipidemia
  • CHF
  • Stroke
  • Antihypertensive Therapy
  • Dangerous Interactions

 

Program Information

Outline

Cardiac Hemodynamics: Beyond Blood Pressure and Heart Rate

  • Preload
  • Afterload
  • Contractility
  • Normal and abnormal electrocardiographic tracings

Antiarrhythmic Agents: Avoid the 3 Most Common Mistakes

  • Class I agents (sodium channel blockers)
  • Class II agents (beta-blockers)
  • Class III agents (potassium channel blockers)
  • Class IV agents (calcium channel blockers)
  • AHA/ACC Anticoagulant Administration Guidelines
  • Nitrates
  • Aspirin
  • Morphine sulfate
  • Beta blockers
  • Fibrinolytic agents
  • Antiplatelet agents
  • Anticoagulants
  • ACE inhibitors
  • Angiotensin receptor blockers (ARB)

Stroke Patients: Avoid 4 Common Medication Errors

  • Ischemic
  • Hypertension: Labetalol, Nitropaste, Nicardipine
  • Hypotension: Crystalloid, Dopamine
  • Thrombolytic agents
  • Antiepileptic medications
  • Dabigatran
  • Hemorrhagic
  • Correct coagulation abnormalities
  • Glucose management
  • Blood pressure control
  • Antiepileptic medications

Metabolic Syndrome and Dyslipidemia Patients: Medications that Should NOT Be Administered Together

  • NCEP ATPIII guidelines
  • Lipid modifying medications
  • Statins
  • Fibrates
  • Resins
  • Niacin
  • Blood glucose control
  • Insulin
  • Oral agents

Congestive Heart Failure: Medications to Start and Avoid Based Upon Patient Presentation Digoxin

  • Nesiritide
  • Diuretics
  • ACE inhibitors
  • ARB
  • Aldosterone antagonists
  • Beta-blockers

WARNING: What the Antihypertensive Therapy Guidelines Do Not Specify

  • Diuretics
  • Loop
  • Thiazide
  • Potassium-sparing
  • ACE inhibitors
  • ARB
  • Beta-blockers
  • Calcium channel blockers
  • Alpha blocking agents
  • Vasodilators
  • Lifestyle modifications

 

Objectives

  1. Describe the four classes of cardiac medications and their effects on the function of the cardiac cycle.
  2. Explain the effects that each class of cardiac medications has on the cardiac cycle.
  3. Identify the classes of medications used to treat acute coronary syndrome.
  4. Discriminate between the treatments for ischemic and hemorrhagic stroke.
  5. Explain the benefits of medications used to treat metabolic syndrome and dyslipidemia.
  6. Analyze the benefits and risks of medications used to treat heart failure.
  7. Define the criteria used to initiate antihypertensive medications after lifestyle modifications have been employed.
  8. Recognize dangerous drug-drug interactions of cardiac and non-cardiac medications.

 

Copyright : 04/12/2016

Pharmacologic Interventions for Pain & Comfort

The complexity of the critically ill patient creates many challenges to providing effective pain relief. These medications have the potential of leading to adverse patient outcomes if not prescribed and administered appropriately. In this session, we will cover Pharmacologic Interventions for:
  • Analgesia
  • Agitation
  • Delirium
  • Thromboembolism Prophylaxis
  • Gastro-intestinal Bleeding Prophylaxis
Objectives
  • Apply prophylactic pharmacologic strategies to promote patient safety and comfort.
  • Assess the most prevalent medications that are prescribed for patients for effective pain relief.
Outline
  • Pain, agitation and delirium
    • Clinical Practice Guideline
    • Pain Assessment
    • Pain Management
      • Opioid Medication
      • Non-opiate Analgesics
      • Sedating Medication
  • Venous Thromboembolism (VTE) Prophylaxis
    • Critically Ill Patients
    • Patients with Cancer
    • DVT
    • Testing for VTE
  • Gastro-Intestinal Bleeding Prophylaxis
    • Background
ADA Needs
We would be happy to accommodate your ADA needs; please call our Customer Service Department for more information at 1-800-844-8260.

Satisfaction Guarantee
Your satisfaction is our goal and our guarantee. Concerns should be addressed to: PO Box 1000, Eau Claire, WI 54702-1000 or call 1-800-844-8260. Copyright : 04/14/2016

Pharmacological Management of Life Threatening Conditions

New medications are being developed at an ever-increasing rate and it can seem overwhelming to keep up with the latest recommendations, guidelines and warnings. In this session, Dr. Langlois will discuss pharmacological management of conditions commonly seen in the critical care setting including:

  • Congestive Heart Failure
  • Myocardial Infarction
  • Stroke
  • Organ Transplant

Objectives

  1. Assess the most prevalent medications that are prescribed for patients with congestive heart failure.
  2. Compare anticoagulants that are most beneficial to the patient with myocardial infarction.

Outline

  • Heart Failure
    • Stages
    • Initial Clinical Assessment
    • Management and Medications
    • LVAD
    • ICD
    • CONTRAINDICATIONS
  • Myocardial Infarction
    • ST-Segment MI
    • Dual Anti-Platelet Therapy
  • Ischemic and Hemorrhagic Stroke
    • Epidemiology
    • Management
    • Aneurysmal Subarachnoid Hemorrhage
      • Diagnosis
      • Parmacologic Treatment
  • Transplant Medications
    • T-Lymphocytes
    • B-Lymphocytes
    • Immunouppression
    • Medications

 

Copyright : 04/14/2016

Pharmacological Management of Infectious Diseases

Choosing an antibacterial agent can be challenging given the emerging trends in bacterial resistance. In this session, Dr. Langlois discusses pharmacokinetic properties and new treatment guidelines for conditions commonly encountered in critical care including:

  • Urinary Tract Infections
  • Skin & Soft Tissue Infections
  • Multiple Drug-Resistant Organisms

Outline

  • Bacterial Basics
    • Cell Envelope
    • Fungal Infections
    • UTI
    • Pevlic Inflammatory Disease
      • PID Therapy
    • Cellulitis
      • Bacterial Causes
      • Therapy for Cellulitis
    • Diabetic Foot Infections
      • Diagnosis and Treatment of Osteomyelitis in Diabetic Ulcer
  • Strategies to Improve Patient Adherence
    • IMS Model
    • Prescribing Practices
    • Antibiotic Resistance
    • Antimicrobial Resistance

 

Program Information

Objectives

  1. Catalogue major classes of antibiotics and their pharmacokinetic characteristics.
  2. Choose appropriate pharmacologic and nonpharmacologic regimens for the prevention and treatment in various patient populations.

Copyright : 04/14/2016

Management of the Patient in Shock

Your patients’ lives depend on your ability to assess and act; there isn’t room for error. Treatment protocols in Managing Shock change frequently and this session will provide you the latest evidence-based management strategies for:

  • Hypovolemic Shock
  • Cardiogenic Shock
  • Neurogenic Shock
  • Obstructive Shock

Objectives

  1. Recognize the cellular alterations that occur during shock
  2. Discriminate how cardiac output differs among the five shock states

Outline

  • Cellular Altercations in Shock
    • Diagnosis
    • Pathophysiologic Shock Mechanisms
  • Types of Shock
    • Cardiogenic Shock
    • Distributive Shock
    • Septic Shock
    • Hypovolemic Shock
    • Obstructive Shock
  • Approaches to Treating All Shock Patients
    • Fluid Resuscitation
    • Vasoactive Agents
    • ECMO
  • Specific Treatments Based on Shock Etiology
  • Ongoing Patient Support and Shock Resuscitation

 

Copyright : 04/14/2016

The ICU Trio in Crisis

The Right Choice for the Situation! In this session, Cyndi discusses quick tips to help you remember:

  • Which IV Fluids & Why
  • How They Work & When to Use Pressor Agents
  • Blood Products - FFP, Platelets, PRBCs, Cryoprecipitate

Objectives

  1. Describe how pressors work and when to use them
  2. Identify which appropriate IV fluids should be used

Outline

  • Cardiac Output
    • Heart Rate
    • Preload
      • Diuretics
      • Vasodilators
    • Afterload
      • Meds that Increase Perfusion Pressure
        • Norepinephrine
        • Dopamine
        • Epinephrine
        • Phenlyephrine
        • Vasopressin
      • Causes of Increases Afterload
        • Vasodilators
        • Ace Inhibitors
        • ARB's
        • Calciium Channel Blocking Agents
  • Contractility
    • Dopamine
    • Dobutamine
    • Digoxin
    • Milrinone
  • IV Fluids and Blood Products
    • Hypotonic Solutions
    • Hypertonic Solutions
    • Colloids
    • Blood Products
      • Packed Red Blood Cells
    • When to Transfuse
      • Platelet Transfusion
      • Fresh Frozen Plasma
      • Cryoprecipitate
      • Reversing Anticoagulation

 

Copyright : 04/15/2016

Emerging Toxicology

Effective assessment for substance use and abuse is vitally important to get the best outcomes for your patients. Marcia will discuss the current trends and challenges encountered with OTC and herbal medication overuse, prescription drug abuse and the new “Street Drugs” of choice. This session will maximize your identification skills and improve your ability to facilitate rapid treatment.

Objectives

  1. Interpret patient presentation to identify possible toxic substance abuse to facilitate rapid and correct treatment.
  2. Categorize symptoms of common of sympathetic and parasympathetic toxidromes and how to intervene quickly.

Outline

  • Basic Principles
  • Management
  • Physical Examination and Assessment
  • Blood Gases and Rules
  • Decontamination Reduce/Remove
    • Gastric Decontamination
      • Gastric Lavage
      • Ipecac
      • Activated Charcoal
        • Drugs that Do Not Absorb to Charcoal
  • Whole Bowel Irrigation
    • Hemoperfusion
    • Toxidromes

 

Copyright : 04/15/2016

The Patient with Multi-System Failure

The patient admitted with Multi-System Failure requires an “all hands on deck” approach. In this session, Dr. Langlois answers the critical questions:

  • What Do We Do First?
  • Which IV Fluids & How Much?
  • Which Antibiotic & Why or Why Not?
  • What are the First Vasopressors to Consider?
  • What Complications are the Most Concerning?

Objectives

  1. Identify and treat patients with multi-system failures
  2. Recognize which patients are at risk for developing chronic kidney disease (CKD) and acute renal failure (ARF)

Outline

  • Multi-System Organ Failure
    • Initial Approach
    • MODs Scoring
  • Oxygenation
    • Calculating Tidal Volume
    • Respiratory Rate
    • Positive End-Expiratory Pressure
    • Mechanical Ventilation
    • ARDS
      • Pathophysiology
      • Ventilation
      • Adjunctive Strategies
      • Pharmalogical Interventions
  • Fluids, Vasopressors, and Blood Products
    • Resuscitation
    • Vasoactive Agents
    • Platelets
    • Managing DIC
  • Cardiovascular Support
    • Hemodynamics of the IABP
    • ECMO
  • Acute Kidney Injury
    • Prevalence of AKI
    • Methods to Assess AKI
  • Neurologic
    • Delirium
  • Sepsis
    • Diagnosis
    • Initial Antimicrobial Therapy
  • Gastrointestinal and Endocrine
    • Glucose Control
    • Nutrition

 

Copyright : 04/15/2016